juan iovanna | Personalized Medicine | Best Researcher Award

Published on by Top Pharmaceutical

juan iovanna | Personalized Medicine | Best Researcher Award

Prof. Dr. juan iovanna, INSERM, France

Prof. Dr. Juan Iovanna è un medico e ricercatore internazionale esperto in oncologia, specializzato nello studio del carcinoma pancreatico. Laureato e dottorato all’Università di Buenos Aires, lavora in Francia dal 1991 presso l’INSERM, dove ha raggiunto il grado di Direttore di Ricerca di Classe Eccezionale. Co-dirige il gruppo “Biologia del cancro pancreatico” al CRCM di Marsiglia e presiede il Programma G7 Cancer. Fondatore di tre start-up biotecnologiche, ha pubblicato 472 articoli con oltre 43.500 citazioni 📚. La sua missione è migliorare la prognosi del tumore pancreatico attraverso ricerca e innovazione terapeutica.

Publication Profile

orcid

Education

Prof. Dr. Juan Iovanna began his academic journey with a degree in Medicine from the University of Buenos Aires, Argentina, in 1982. Driven by a passion for biomedical research, he pursued a Ph.D. in Biomedical Sciences at the same university, which he completed in 1986. 🧬 His doctoral thesis, titled “Meccanismi di regolazione della sintesi proteica in modelli cellulari di stress,” focused on the mechanisms regulating protein synthesis in cellular stress models. 🧪 This foundational work laid the groundwork for his future contributions to medical science and molecular biology.

Experience

🔬 Prof. Dr. Juan Iovanna has built an illustrious career in cancer research. In 1991, he began as a researcher at INSERM in France and was promoted to Research Director in 1993 and again in 1998. 🚀 In 2011, he achieved the prestigious title of Directeur de Recherche de Classe Exceptionnelle (DRCE). From 2011 to 2023, he served as Vice-Director of the Marseille Cancer Research Center (CRCM) and led its Translational Medicine Department. 🧫 He also directed the “Pancreatic Cancer Biology” group from 1999 to 2023. Since 2024, he co-directs this group with Dr. Nelson Dusetti and serves as Emeritus Research Director.

Distinctions and Awards

Prof. Dr. Juan Iovanna has received numerous prestigious awards and honors throughout his career. In 2017, he was awarded the Jean Valade Prize by the Fondation de France for his outstanding contributions to biomedical research. 🌍 In 2018, he received the RAICES Award from Argentina’s Ministry of Science, Technology, and Innovation. 🇫🇷 In 2021, the French Senate honored him with a commemorative medal. In 2023, he was named Honorary Professor at the National University Arturo Jauretche (UNAJ), and in 2024, he was recognized as a Distinguished and Honorary Member of the University of Buenos Aires.

Research Focus

Prof. Dr. Juan Iovanna’s research is centered on precision oncology, with a primary focus on pancreatic ductal adenocarcinoma (PDAC). His work integrates transcriptomics, drug resistance mechanisms, redox metabolism, and multi-omics modeling to uncover novel therapeutic vulnerabilities and biomarkers. He contributes to the development of RNA signatures (like GemPred) to predict chemotherapy response, and investigates KRAS inhibition and therapy-induced senescence as pathways to reverse drug resistance. His translational studies aim to optimize personalized treatment strategies for pancreatic cancer patients, bridging molecular insights with clinical application.

Publication Top Notes

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma

The PancreasView gemcitabine transcriptomic signature predicts response to gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer

Reply to the Letter to the Editor regarding ‘Chi-squared and P-values vs. machine learning feature selection by Y. Takefuji’

Reply to the Letter to the Editor ‘AI-assisted personalized adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma’ by Y. Shimazu

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction

Francesco Ceppa | Precision Medicine | Excellence in Research

Published on by Top Pharmaceutical

Francesco Ceppa | Precision Medicine | Excellence in Research

Dr Francesco Ceppa,Università cattolica del sacro cuore,Italy

Dr. Francesco Ceppa 👨‍⚕️Born on May 15, 1994, in Pescara, Italy 🇮🇹, Dr. Francesco Ceppa is a dedicated medical professional specializing in Emergency Medicine at the prestigious A. Gemelli Hospital, Università Cattolica del Sacro Cuore 🏥. A graduate in Medicine and Surgery 🎓 (2020), he has excelled with advanced certifications like Advanced Life Support (ALS) 🩺. Dr. Ceppa gained invaluable experience as a COVID-19 vaccinator and through clinical roles in emergency medicine and abdominal surgery. Fluent in Italian 🇮🇹 and proficient in English 🌍, he combines excellent interpersonal 🤝, organizational 📋, and technical skills 💻 to advance patient care.

Publication Profile

orcid

 Academic Background

Dr. Francesco Ceppa is a dedicated medical professional who graduated from the Università Cattolica del Sacro Cuore with a degree in Medicine and Surgery, earning an impressive score of 101/110 🎓. His strong academic foundation is complemented by an outstanding high school diploma 📚 and proficiency in English at the C1 level 🌍. In line with his commitment to excellence in healthcare, Dr. Ceppa obtained an Advanced Life Support (ALS) certification in 2022 🩺, equipping him to handle critical medical situations with expertise. His achievements highlight his passion for advancing his skills and making a meaningful impact in the field of medicine. 💡✨

Professional Experience

Dr. Ceppa has showcased exceptional expertise through various impactful roles. 💉 During the COVID-19 pandemic, he actively contributed to public health by participating in antigen testing and vaccination campaigns. 🩺 His journey in Emergency Medicine began with a residency at the renowned Agostino Gemelli University Hospital, highlighting his commitment to critical care and acute medical settings. 🚨 Additionally, Dr. Ceppa has been involved in clinical collaborations with key departments, including surgery and translational medicine, fostering interdisciplinary connections that may pave the way for groundbreaking research. 🔬 His dedication exemplifies a blend of hands-on care and forward-thinking innovation. 🌟

Research Contributions

Dr. Francesco Ceppa is a dedicated medical professional with exceptional expertise in emergency medicine, holding an Advanced Life Support (ALS) certification 🩺. Renowned for his technical proficiency, he is rated “excellent” in utilizing medical equipment and computer systems for efficient healthcare delivery 💻. His outstanding teamwork and organizational skills 🤝 ensure seamless collaboration in research and clinical settings. However, his CV lacks explicit mention of peer-reviewed publications, conference presentations, research grants, or independent projects, as well as specific contributions to advancing medical science or methodologies. Strengthening these areas could further highlight his impact and expertise in the medical field. 📚✨

Dr. Alberto Camacho Morales|Personalized Medicine|Excellence in Researchd

Published on by Top Pharmaceutical

Dr. Alberto Camacho Morales|Personalized Medicine|Excellence in Research

Dr. Alberto Camacho Morales at Abdul wali khan university mardan,Pakistan

PROFILE  

 

Google scholar

Orcid

scopus.

Early Academic Pursuits 🎓

Alberto Camacho Morales’s academic journey is a testament to his dedication to biomedical sciences. After earning a Bachelor’s degree in Biology from the Faculty of Sciences at the National Autonomous University of Mexico (UNAM) in 1999, he pursued advanced studies with unwavering focus. Driven by a passion for understanding cellular processes, he completed a Ph.D. in Biomedical Sciences at the Institute of Cellular Physiology (UNAM) in 2007. His doctoral research laid a strong foundation for his specialization in metabolic and neurophysiological sciences. Alberto’s pursuit of academic excellence culminated in a postdoctoral fellowship at the Institute of Metabolic Science, University of Cambridge, England (2007–2011). These experiences solidified his expertise in metabolic programming, a field where he has become a pioneering voice.

Professional Endeavors 🏢

Since completing his postdoctoral studies, Dr. Camacho Morales has held several influential roles in academia and research. He began his teaching career as a professor-researcher at the School of Medicine, Tecnológico de Monterrey (2011). By 2012, he transitioned to the Faculty of Medicine, Autonomous University of Nuevo León (UANL), where he assumed roles that included leading molecular and biochemical studies and coordinating critical academic programs for graduate and undergraduate students.

Dr. Camacho has also extended his expertise beyond academia as a President and Member of Biosecurity and Research Committees at Accelerium Clinical Research, a testament to his ability to bridge research and its practical applications in clinical settings. His 17+ years of professional experience in translational science have equipped him to consult and guide preclinical and clinical research projects effectively.

Contributions and Research Focus 🧠

Dr. Camacho Morales’s research contributions have significantly impacted the understanding of metabolic disorders and neurophysiological programming. His primary areas of research include:

Maternal Neuroinflammation and Behavioral Disorders: Investigating how maternal obesity during pregnancy programs neuroinflammation, contributing to behavioral abnormalities in offspring.
Neuronal Plasticity and Addiction: Understanding the role of neuronal plasticity in hypercaloric food addiction and its implications in obesity development.
Metabolic Programming During Pregnancy: Exploring how prenatal metabolic programming influences metabolic and behavioral outcomes in offspring.
Biomarkers of Metabolic Damage: Identifying blood biomarkers associated with metabolic damage in obese individuals, with and without Type 2 diabetes.
Dr. Camacho’s research combines cutting-edge methodologies in molecular biology, neuroscience, and endocrinology, addressing global challenges like obesity, diabetes, and neuropsychiatric disorders.

Accolades and Recognition 🏆

Dr. Camacho Morales’s exemplary work has earned him numerous awards and recognitions:

National Researcher Level III (2024): A prestigious distinction from Mexico’s National System of Researchers.
First Place in Basic Science Research (2023): UANL acknowledged his groundbreaking work in metabolic programming.
Multiple accolades at state and national levels, including awards in research competitions (e.g., Funsalud Prize for Basic Research in 2018).
Marie Curie Postdoctoral Fellowship: A two-year fellowship at the University of Cambridge, funded by the European Union.
His sustained commitment to scientific excellence is also evident in his editorial roles for esteemed journals like Frontiers in Endocrinology and Molecular Psychiatry.

Impact and Influence 🌍

As a leader in his field, Dr. Camacho Morales has made significant contributions to the academic community. His roles as a professor and mentor at UANL have inspired countless students to pursue careers in biomedical sciences. He coordinates critical courses in molecular biology, biochemistry, and cellular biology for master’s and doctoral programs, shaping future researchers’ perspectives.

His editorial and peer-review roles for high-impact journals, such as Diabetes and Molecular Neuroscience, demonstrate his influence in advancing global biomedical research. By reviewing and editing scientific literature, he has contributed to the integrity and progression of his field.

Legacy and Future Contributions 🌱

Dr. Camacho Morales’s work has lasting implications for understanding and treating metabolic and neurophysiological disorders. His research on the programming of metabolic and behavioral outcomes in offspring provides valuable insights for developing preventive and therapeutic strategies.

 

🎓Publication 

Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice

  • Authors   : Xavier Prieur, Crystal YL Mok, Vidya R Velagapudi, Vanessa Núñez, Lucía Fuentes, David Montaner, Ko Ishikawa, Alberto Camacho, Nuria Barbarroja, Stephen O’Rahilly, Jaswinder K Sethi, Joaquin Dopazo, Matej Orešič, Mercedes Ricote, Antonio Vidal-Pui
  • Journal    :American Diabetes Association
  • Year         :2011

Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death

    • Authors   : Alberto Camacho, Lourdes Massieu
    • Journal    : Archives of medical research
    • Year         :2006

Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum

  • Authors   : Erika Rodrı́guez-Martı́nez, Alberto Camacho, Perla D Maldonado, José Pedraza-Chaverrı́, Daniel Santamarı́a, Sonia Galván-Arzate, Abel Santamarı́a
  • Journal    : Brain research
  • Year         :2000

In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum

  • Authors   :Abel Santamaría, María E Jiménez-Capdeville, Alberto Camacho, Erika Rodríguez-Martínez, Abigail Flores, Sonia Galván-Arzate
  • Journal     :Neuroreport
  • Year         :2001

Microglia activation due to obesity programs metabolic failure leading to type two diabetes

  • Authors   : R Maldonado-Ruiz, L Montalvo-Martínez, Lizeth Fuentes-Mera, A Camacho
  • Journal    : Nutrition & diabetes
  • Year         :2017

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Prof Dr. Piotr Fiedor at Department of General and Transplantation Surgery, Medical University of Warsaw,Poland

PROFILE  

 

Scopus

Early Academic Pursuits 🎓

Professor Piotr Fiedor, MD, PhD, embarked on his medical journey with a strong focus on surgery and transplantation. His academic pursuits began at Warsaw Medical University, where he completed his initial medical training. Earning both his MD and PhD, Fiedor developed a passion for complex medical fields such as transplantation immunology and biotechnology. During his early career, he broadened his expertise with international fellowships, notably at Columbia University in the United States, between 1993 and 1996, where he deepened his knowledge in transplantation immunology and immunomodulation. This fellowship solidified his expertise and set the stage for his contributions to both academia and the field of transplantation surgery.

Professional Endeavors 🔬

Professor Fiedor’s professional career has been a blend of clinical practice, research, and leadership roles. Since 1995, he has served in the Department of General and Transplantation Surgery at Warsaw Medical University. His responsibilities in this department include managing clinical procedures, conducting high-level research, and overseeing scientific programs. In addition to his academic role, Fiedor held the prestigious position of Chief Executive Officer at the National Medicine Institute in Warsaw from 2015 to 2017. During this period, he was responsible for overseeing the evaluation of medicinal products, ensuring high-quality standards, and coordinating with the European Directorate for the Quality of Medicines & HealthCare (EDQM).

Fiedor’s influence extends to regulatory affairs, particularly as the Polish Member of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) from 2010 to 2017. His contributions in the CHMP involved acting as Rapporteur or Co-Rapporteur for more than 120 innovative medicinal products, ensuring their safe and effective use across Europe. His regulatory expertise continues, as he now serves as an Expert for the CHMP Scientific Advice Group.

Contributions and Research Focus 🧬

Professor Fiedor’s research has had a profound impact on the fields of transplant surgery, oncology, and immunology. His scientific work has addressed critical challenges in organ transplantation, including the immunological complications of transplants and strategies for improving graft survival. His work on the hemodynamic changes in organ donors before harvesting has been particularly influential, contributing to improved transplantation outcomes.

International collaborations have been a cornerstone of his research. He has worked with institutions like L’Aquila University in Italy, Columbia University and Ohio State University in the United States, and the Hebrew University of Jerusalem in Israel. His participation in 15 national scientific projects supported by Poland’s National Scientific Committee and two research grants from the National Institutes of Health (NIH) in the USA highlight his commitment to advancing medical science on a global scale.

Accolades and Recognition 🏅

Throughout his career, Professor Fiedor has received numerous awards recognizing his contributions to medical science, education, and public health. Some of his most notable honors include:

  • The Gold Cross of Merit awarded by the President of Poland in 2011 for his exceptional service to medicine.
  • The National Education Committee Medal in 2009 for his contributions to the advancement of medical education.
  • Multiple scientific awards from Warsaw Medical University, including team and individual awards for groundbreaking research on organ transplantation and immunology.
  • A notable achievement is his 2012 First-Degree Team Teaching Award from the Rector of Warsaw Medical University for co-authoring a textbook on disaster medicine.

These awards underline his influence on both medical practice and education.

Impact and Influence 🌍

Professor Fiedor’s impact extends beyond his clinical and research achievements. As a member of international organizations like the International Transplantation Society and the American Society of Transplant Surgeons (ASTS), he has helped shape the global discourse on transplant surgery and immunology. His work has led to significant advances in transplantation procedures, particularly concerning immunosuppressive therapies that reduce the risk of organ rejection.

In addition to his clinical and research accomplishments, Fiedor has played a vital role in shaping regulatory policies for medicinal products in Poland and Europe. His expertise in clinical trials, particularly through his work at the National Medicines Institute and his leadership in Good Clinical Practice (GCP) inspections, has influenced the standards of medical product approvals across Europe.

Legacy and Future Contributions 🌟

Professor Fiedor’s legacy lies in his multifaceted contributions to medicine. He has influenced generations of surgeons and medical professionals through his teaching roles at Warsaw Medical University. His over 210 scientific papers and 19 book chapters serve as valuable resources for both current and future medical researchers. His dedication to personalized medicine and biotechnology continues through his involvement in organizations such as the International Consortium for Personalized Medicine (IC PerMed), where he plays a role in advancing tailored healthcare solutions.

Looking forward, Fiedor’s ongoing work with European Joint Programs for Rare Diseases and the National Center for Research and Development’s Alpha Bridge Project ensures that he will continue to contribute to innovative research in the field of rare diseases and healthy society initiatives.

Conclusion 🔖

Professor Piotr Fiedor’s career stands as a testament to his dedication to the fields of surgery, immunology, and transplantation. With a rich history of academic achievements, clinical leadership, and regulatory expertise, his contributions have reshaped modern medicine, particularly in the realms of organ transplantation and medicinal product evaluation. His legacy continues to inspire both his peers and the next generation of medical professionals.

🎓Publication 

One Molecule, Many Faces: Repositioning Cardiovascular Agents for Advanced Wound Healing

  • Authors   : Gościniak, A., Stasiłowicz-Krzemień, A., Michniak-Kohn, B., Fiedor, P., Cielecka-Piontek, J.
  • Journal    :Molecules
  • Year         :2024

Are Current Educational and Therapeutic Programs, Directed at Rare Disease Transplant Candidates and Recipients, Sufficient to Support Them on the Path From Diagnosis to Life After Allogenic Transplantation?—Recommendations for Member State Policymakers

  • Authors   : Bartoszewicz, M., Prokop, P., Kosieradzki, M., Fiedor, P.
  • Journal    :Transplantation Proceedings
  • Year         :2024

Comparison of Long-Term Outcomes of Surgical Treatment of Human Papillomavirus-Dependent Neoplastic Lesions in Patients With Chronic Immunosuppression After Allogenic Organ Transplantation and Patients With Primary or Acquired Immunodeficiency—A One-Center Experience

  • Authors   : Prokop, P., Bartoszewicz, M., Gardyszewska, A., Kosieradzki, M., Fiedor, P.
  • Journal    :ransplantation Proceedings
  • Year         :2024

Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial

  • Authors   :Rejdak, K., Fiedor, P., Bonek, R., … Kaczor, M., Grieb, P.
  • Journal    :European Journal of Neurology
  • Year         :2024

POLCOVID: a multicenter multiclass chest X-ray database (Poland, 2020–2021)

  • Authors   :Suwalska, A., Tobiasz, J., Prazuch, W., … Cieszanowski, A., Polanska, J.
  • Year         :2023